These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9890417)

  • 1. A human cell line constitutively expressing HIV-1 Gag and Gag-Pol gene products.
    Wang CT; Li JJ; Lai HY; Hu BS
    J Med Virol; 1999 Jan; 57(1):17-24. PubMed ID: 9890417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase.
    Kräusslich HG; Ochsenbauer C; Traenckner AM; Mergener K; Fäcke M; Gelderblom HR; Bosch V
    Virology; 1993 Feb; 192(2):605-17. PubMed ID: 8421902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles.
    Karacostas V; Wolffe EJ; Nagashima K; Gonda MA; Moss B
    Virology; 1993 Apr; 193(2):661-71. PubMed ID: 7681610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of human immunodeficiency virus type 1 Pr160 gag-pol mutants with truncations downstream of the protease domain.
    Liao WH; Wang CT
    Virology; 2004 Nov; 329(1):180-8. PubMed ID: 15476885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of a flexible cell line with regulatable, high-level expression of HIV Gag/Pol particles capable of packaging HIV-derived vectors.
    Sparacio S; Pfeiffer T; Schaal H; Bosch V
    Mol Ther; 2001 Apr; 3(4):602-12. PubMed ID: 11319923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The virus-associated human immunodeficiency virus type 1 Gag-Pol carrying an active protease domain in the matrix region is severely defective both in autoprocessing and in trans processing of gag particles.
    Chen SW; Chiu HC; Liao WH; Wang FD; Chen SS; Wang CT
    Virology; 2004 Jan; 318(2):534-41. PubMed ID: 14972522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the protease gene of human immunodeficiency virus type 1 affect release and stability of virus particles.
    Park J; Morrow CD
    Virology; 1993 Jun; 194(2):843-50. PubMed ID: 8503189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.
    Goodenow MM; Bloom G; Rose SL; Pomeroy SM; O'Brien PO; Perez EE; Sleasman JW; Dunn BM
    Virology; 2002 Jan; 292(1):137-49. PubMed ID: 11878916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive regions of pol are required for efficient human immunodeficiency virus polyprotein processing and particle maturation.
    Quillent C; Borman AM; Paulous S; Dauguet C; Clavel F
    Virology; 1996 May; 219(1):29-36. PubMed ID: 8623542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues.
    Meek TD; Lambert DM; Dreyer GB; Carr TJ; Tomaszek TA; Moore ML; Strickler JE; Debouck C; Hyland LJ; Matthews TJ
    Nature; 1990 Jan; 343(6253):90-2. PubMed ID: 1688646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The virion-associated Gag-Pol is decreased in chimeric Moloney murine leukemia viruses in which the readthrough region is replaced by the frameshift region of the human immunodeficiency virus type 1.
    Gendron K; Dulude D; Lemay G; Ferbeyre G; Brakier-Gingras L
    Virology; 2005 Apr; 334(2):342-52. PubMed ID: 15780884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
    J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo processing of Pr160gag-pol from human immunodeficiency virus type 1 (HIV) in acutely infected, cultured human T-lymphocytes.
    Lindhofer H; von der Helm K; Nitschko H
    Virology; 1995 Dec; 214(2):624-7. PubMed ID: 8553565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative.
    Müller B; Daecke J; Fackler OT; Dittmar MT; Zentgraf H; Kräusslich HG
    J Virol; 2004 Oct; 78(19):10803-13. PubMed ID: 15367647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-2 viral protein X association with the GAG p27 capsid protein.
    Horton R; Spearman P; Ratner L
    Virology; 1994 Mar; 199(2):453-7. PubMed ID: 8122374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of human immunodeficiency virus type 1 integrase mutants.
    Ansari-Lari MA; Donehower LA; Gibbs RA
    Virology; 1995 Aug; 211(1):332-5. PubMed ID: 7544046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A domain directly C-terminal to the major homology region of human immunodeficiency type 1 capsid protein plays a crucial role in directing both virus assembly and incorporation of Gag-Pol.
    Chien AI; Liao WH; Yang DM; Wang CT
    Virology; 2006 Apr; 348(1):84-95. PubMed ID: 16442581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.
    Mautino MR; Keiser N; Morgan RA
    J Virol; 2001 Apr; 75(8):3590-9. PubMed ID: 11264348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cotransfection of mutated forms of human immunodeficiency virus type 1 Gag-Pol with wild-type constructs can interfere with processing and viral replication.
    Morin N; Cherry E; Li X; Wainberg MA
    J Hum Virol; 1998; 1(3):240-7. PubMed ID: 10195247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
    BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
    J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.